Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response

Journal of Experimental Medicine

Volumn 207, Issue 9, 2010, Pages 1981-1993

  Markowska, Anna I ^a   Liu, Fu Tong ^b   Panjwani, Noorjahan ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BETA LACTOSE; DOMINANT NEGATIVE GALECTIN 3; FOCAL ADHESION KINASE; GALECTIN 3; LACTOSE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VITRONECTIN RECEPTOR;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN;

ANIMALS; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; GALECTIN 3; HUMANS; INTEGRIN ALPHAVBETA3; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN BINDING; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956233662     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20090121     Document Type: Article

References (57)

1. Ahmad, N., H.J. Gabius, S. André, H. Kaltner, S. Sabesan, R. Roy, B. Liu, F. Macaluso, and C.F. Brewer. 2004. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J. Biol. Chem. 279:10841-10847. doi:10.1074/jbc. M312834200
2. Altin, J.G., and E.B. Pagler. 1995. A one-step procedure for biotinylation and chemical cross-linking of lymphocyte surface and intracellular membrane-associated molecules. Anal. Biochem. 224:382-389. doi:10.1006/abio. 1995.1054
3. Bellis, S.L. 2004. Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins. Biochim. Biophys. Acta. 1663:52-60. doi:10.1016/j.bbamem.2004.03.012
4. Borges, E., Y. Jan, and E. Ruoslahti. 2000. Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain. J. Biol. Chem. 275:39867-39873. doi:10.1074/jbc.M007040200
5. Braren, R., H. Hu, Y.H. Kim, H.E. Beggs, L.F. Reichardt, and R. Wang. 2006. Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J. Cell Biol. 172:151-162. doi:10.1083/jcb.200506184
6. Breier, G. 2000. Angiogenesis in embryonic development - a review. Placenta. 21:S11-S15. doi:10.1053/plac.1999.0525
7. Brooks, P.C. 1996. Role of integrins in angiogenesis. Eur. J. Cancer. 32:2423-2429. doi:10.1016/S0959-8049(96)00381-4
8. Brooks, P.C., R.A. Clark, and D.A. Cheresh. 1994. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 264:569-571. doi:10.1126/science.7512751
9. Carmeliet, P., and R.K. Jain. 2000. Angiogenesis in cancer and other diseases. Nature. 407:249-257. doi:10.1038/35025220
10. Cross, M.J., and L. Claesson-Welsh. 2001. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 22:201-207. doi:10.1016/S0165-6147(00)01676-X
11. Cummings, R.D., and S. Kornfeld. 1982. Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. J. Biol. Chem. 257:11230-11234.
12. Dong, S., and R.C. Hughes. 1997. Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen). Glycoconj. J. 14:267-274. doi:10.1023/A: 1018554124545
13. Drake, C.J., D.A. Cheresh, and C.D. Little. 1995. An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. J. Cell Sci. 108:2655-2661.
14. Eliceiri, B.P. 2001. Integrin and growth factor receptor crosstalk. Circ. Res. 89:1104-1110. doi:10.1161/hh2401.101084
15. Eliceiri, B.P., and D.A. Cheresh. 2001. Adhesion events in angiogenesis. Curr. Opin. Cell Biol. 13:563-568. doi:10.1016/S0955-0674(00)00252-0
16. Fraser, H.M., and S.F. Lunn. 2000. Angiogenesis and its control in the female reproductive system. Br. Med. Bull. 56:787-797. doi:10.1258/ 0007142001903364
17. Friedlander, M., P.C. Brooks, R.W. Shaffer, C.M. Kincaid, J.A. Varner, and D.A. Cheresh. 1995. Definition of two angiogenic pathways by distinct alpha v integrins. Science. 270:1500-1502. doi:10.1126/science.270.5241.1500
18. Gardner, T.W., D.A. Antonetti, A.J. Barber, K.F. LaNoue, and S.W. Levison. 2002. Diabetic retinopathy: more than meets the eye. Surv. Ophthalmol. 47:S253-S262. doi:10.1016/S0039-6257(02)00387-9
19. Giancotti, F.G., and E. Ruoslahti. 1999. Integrin signaling. Science. 285:1028-1032. doi:10.1126/science.285.5430.1028
20. Goetz, J.G., B. Joshi, P. Lajoie, S.S. Strugnell, T. Scudamore, L.D. Kojic, and I.R. Nabi. 2008. Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1. J. Cell. Biol. 180:1261-1275.
21. Granovsky, M., J. Fata, J. Pawling, W.J. Muller, R. Khokha, and J.W. Dennis. 2000. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat. Med. 6:306-312. doi:10.1038/73163
22. Gu, Y.C., T.R. Bauer Jr., M.R. Ackermann, C.W. Smith, M.E. Kehrli Jr., M.F. Starost, and D.D. Hickstein. 2004. The genetic immunodeficiency disease, leukocyte adhesion deficiency, in humans, dogs, cattle, and mice. Comp. Med. 54:363-372.
23. Guo, W., and F.G. Giancotti. 2004. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5:816-826. doi:10.1038/nrm1490
24. Guo, H.B., I. Lee, B.T. Bryan, and M. Pierce. 2005. Deletion of mouse embryo fibroblast N-acetylglucosaminyltransferase V stimulates alpha5beta1 integrin expression mediated by the protein kinase C signaling pathway. J. Biol. Chem. 280:8332-8342. doi:10.1074/jbc.M413532200
25. Hirabayashi, J., T. Hashidate, Y. Arata, N. Nishi, T. Nakamura, M. Hirashima, T. Urashima, T. Oka, M. Futai, W.E. Muller, et al. 2002. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim. Biophys. Acta. 1572:232-254.
26. Hodivala-Dilke, K.M., A.R. Reynolds, and L.E. Reynolds. 2003. Integrins in angiogenesis: multitalented molecules in a balancing act. Cell Tissue Res. 314:131-144. doi:10.1007/s00441-003-0774-5
27. Hsu, D.K., R.I. Zuberi, and F.T. Liu. 1992. Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin. J. Biol. Chem. 267:14167-14174.
28. Hsu, D.K., R.Y. Yang, Z. Pan, L. Yu, D.R. Salomon, W.P. Fung-Leung, and F.T. Liu. 2000. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am. J. Pathol. 156:1073-1083.
29. Hynes, R.O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell. 110:673-687. doi:10.1016/S0092-8674(02)00971-6
30. Ilic, D., Y. Furuta, S. Kanazawa, N. Takeda, K. Sobue, N. Nakatsuji, S. Nomura, J. Fujimoto, M. Okada, and T. Yamamoto. 1995. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature. 377:539-544. doi:10.1038/377539a0
31. Ilic, D., B. Kovacic, K. Johkura, D.D. Schlaepfer, N. Tomasević, Q. Han, J.B. Kim, K. Howerton, C. Baumbusch, N. Ogiwara, et al. 2004. FAK promotes organization of fibronectin matrix and fibrillar adhesions. J. Cell Sci. 117:177-187. doi:10.1242/jcs.00845
32. John, C.M., H. Leffler, B. Kahl-Knutsson, I. Svensson, and G.A. Jarvis. 2003. Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer. Clin. Cancer Res. 9:2374-2383.
33. Kalluri, R. 2003. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer. 3:422-433. doi:10.1038/nrc1094
34. Kenyon, B.M., E.E. Voest, C.C. Chen, E. Flynn, J. Folkman, and R.J. D'Amato. 1996. A model of angiogenesis in the mouse cornea. Invest. Ophthalmol. Vis. Sci. 37:1625-1632.
35. Koch, A.E. 1998. Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 41:951-962. doi:10.1002/1529-0131(199806)41: 6〈951::AID-ART2〉3.0.CO;2-D
36. Kulkarni, A.D., and B.D. Kuppermann. 2005. Wet age-related macular degeneration. Adv. Drug Deliv. Rev. 57:1994-2009. doi:10.1016/j.addr.2005.09.003
37. Lagana, A., J.G. Goetz, P. Cheung, A. Raz, J.W. Dennis, and I.R. Nabi. 2006. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol. Cell. Biol. 26:3181-3193. doi:10.1128/MCB.26.8. 3181-3193.2006
38. Leavesley, D.I., M.A. Schwartz, M. Rosenfeld, and D.A. Cheresh. 1993. Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell Biol. 121:163-170. doi:10.1083/jcb.121.1.163
39. Lock, J.G., B. Wehrle-Haller, and S. Strömblad. 2008. Cell-matrix adhesion complexes: master control machinery of cell migration. Semin. Cancer Biol. 18:65-76. doi:10.1016/j.semcancer.2007.10.001
40. Mahabeleshwar, G.H., W. Feng, D.R. Phillips, and T.V. Byzova. 2006. Integrin signaling is critical for pathological angiogenesis. J. Exp. Med. 203:2495-2507. doi:10.1084/jem.20060807
41. Matarrese, P., O. Fusco, N. Tinari, C. Natoli, F.T. Liu, M.L. Semeraro, W. Malorni, and S. Iacobelli. 2000. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int. J. Cancer. 85:545-554. doi:10.1002/(SICI)1097-0215(20000215)85:4〈545::AID-IJC17〉3.0.CO;2-N (Pubitemid 30075135)
42. Nangia-Makker, P., Y. Honjo, R. Sarvis, S. Akahani, V. Hogan, K.J. Pienta, and A. Raz. 2000. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am. J. Pathol. 156:899-909.
43. Nangia-Makker, P., V. Hogan, Y. Honjo, S. Baccarini, L. Tait, R. Bresalier, and A. Raz. 2002. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J. Natl. Cancer Inst. 94:1854-1862.
44. Ohannesian, D.W., D. Lotan, P. Thomas, J.M. Jessup, M. Fukuda, H.J. Gabius, and R. Lotan. 1995. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res. 55:2191-2199.
45. Parsons, J.T. 2003. Focal adhesion kinase: the first ten years. J. Cell Sci. 116:1409-1416. doi:10.1242/jcs.00373
46. Partridge, E.A., C. Le Roy, G.M. Di Guglielmo, J. Pawling, P. Cheung, M. Granovsky, I.R. Nabi, J.L. Wrana, and J.W. Dennis. 2004. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science. 306:120-124. doi:10.1126/science.1102109
47. Pola, R., L.E. Ling, M. Silver, M.J. Corbley, M. Kearney, R. Blake Pepinsky, R. Shapiro, F.R. Taylor, D.P. Baker, T. Asahara, and J.M. Isner. 2001. The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat. Med. 7:706-711. doi:10.1038/89083
48. Price, M.O., R.W. Thompson Jr., and F.W. Price Jr. 2003. Risk factors for various causes of failure in initial corneal grafts. Arch. Ophthalmol. 121:1087-1092. doi:10.1001/archopht.121.8.1087
49. Saravanan, C., F.T. Liu, I.K. Gipson, and N. Panjwani. 2009. Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on alpha3beta1 integrin. J. Cell Sci. 122:3684-3693. doi:10.1242/jcs.045674
50. Shen, T.L., A.Y. Park, A. Alcaraz, X. Peng, I. Jang, P. Koni, R.A. Flavell, H. Gu, and J.L. Guan. 2005. Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J. Cell Biol. 169:941-952. doi:10.1083/jcb.200411155
51. Soldi, R., S. Mitola, M. Strasly, P. Defilippi, G. Tarone, and F. Bussolino. 1999. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 18:882-892. doi:10.1093/emboj/18. 4.882
52. Stillman, B.N., D.K. Hsu, M. Pang, C.F. Brewer, P. Johnson, F.T. Liu, and L.G. Baum. 2006. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J. Immunol. 176:778-789.
53. Storgard, C.M., D.G. Stupack, A. Jonczyk, S.L. Goodman, R.I. Fox, and D.A. Cheresh. 1999. Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J. Clin. Invest. 103:47-54. doi:10.1172/JCI3756
54. Stupack, D.G., and D.A. Cheresh. 2004. Integrins and angiogenesis. Curr. Top. Dev. Biol. 64:207-238. doi:10.1016/S0070-2153(04)64009-9
55. Tonnesen, M.G., X. Feng, and R.A. Clark. 2000. Angiogenesis in wound healing. J. Investig. Dermatol. Symp. Proc. 5:40-46. doi:10.1046/j.1087-0024. 2000.00014.x
56. Vaisman, N., D. Gospodarowicz, and G. Neufeld. 1990. Characterization of the receptors for vascular endothelial growth factor. J. Biol. Chem. 265:19461-19466.
57. Yang, E., J.S. Shim, H.J. Woo, K.W. Kim, and H.J. Kwon. 2007. Aminopeptidase N/CD13 induces angiogenesis through interaction with a pro-angiogenic protein, galectin-3. Biochem. Biophys. Res. Commun. 363:336-341. doi:10.1016/j.bbrc.2007.08.179